Market Overview

Flu Activity Continues to Rise, Related Prescriptions Up 12% from Last Week; Watch CVS, Walgreen

Share:
Related CVS
AcelRx: Replacing Morphine With Department Of Defense Funding
Headline Risk Haunts PBMs As Drug Pricing Debate Intensifies
Related WAG
Where Are People Using Apple Pay?
Early Global News: Record Online Sales, 400% Jump In Tinder Users, China Experiences Worst Drop In Months

Lazard Capital Market's Tom Galluci issued an update on flu activity Monday morning following a note from December 17th which suggested CVS (NYSE: CVS) and Walgreen (NYSE: WAG) could benefit from increased cases of the virus.

The analyst said flu activity was up 12 percent from last week and up a very concerning 94 percent from the same week last year. Prescriptions for cold, cough and/or flu drugs has surged 61 percent from December 2011.

Galluci believes this increase in activity is likely to have a greater effect on hospital volume metrics rather than earnings as a lower-margin business.

Lazard maintains a Buy rating on CVS and a Neutral rating on Walgreen shares.

Latest Ratings for CVS

DateFirmActionFromTo
Feb 2017BairdDowngradesOutperformNeutral
Dec 2016JefferiesAssumesBuyHold
Oct 2016UBSInitiates Coverage onBuy

View More Analyst Ratings for CVS
View the Latest Analyst Ratings

Posted-In: Analyst Color Analyst Ratings

 

Related Articles (CVS + RAD)

View Comments and Join the Discussion!